Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Towa Pharmaceutical Co. Ltd.

Latest From Towa Pharmaceutical Co. Ltd.

Towa’s New Overseas Business Boosted By COVID-19 Demand

Japan’s Towa Pharmaceutical endured a mixed financial first quarter, seeing the April round of Japanese National Health Insurance pricing measures bite into domestic sales while its new overseas business thrived as COVID-19 pushed up demand.

Sales & Earnings Generic Drugs

Towa Expects To Grow By Over A Third With Pensa

Towa says it expects consolidating the Pensa business it acquired earlier this year to boost its sales by more than a third in its current financial year. Meanwhile, the Japanese firm has reported sales ahead by 5% in the year ended March 2020 on the back of new launches, as well as growth in profits despite local price cuts.

Sales & Earnings Deals

Asia Deal Watch: Strides Obtains 18 US ANDAs From Pharmaceutics

Deal news from Strides Pharma, Pharmaceutics Intl., Cipla, Wanbury, AstraZeneca, Syntekabio, Arctoris, Mundipharma, Samsung Bioepis…

Deals Business Strategies

Towa Hits Profit Target Three Months Early

Japan’s Towa has almost achieved its full-year operating profit goal in the first nine months of its financial year thanks to lower costs.

Sales & Earnings Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
UsernamePublicRestriction

Register